Platinum-silver nano-cluster protected by erlotinib and preparation method thereof
A technology of erlotinib and nano-clusters, applied in the field of erlotinib-protected platinum-silver nano-clusters and its preparation, which can solve the problems of lack of light-emitting functional structure design and blankness, and achieve excellent luminescent performance and low preparation cost , the effect of high yield
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] 0.1 mmol of Pt(tht) 2 Cl 2 and 0.8 mmol [Ag(Erlotinib)] n Mix and dissolve in 6 mL of dichloromethane and 3 mL of methanol mixed solvent, stir and react at room temperature for 2 hours under anaerobic conditions to obtain a yellow clear solution, and then add 0.2 mmol of NaBH dropwise 4 methanol solution, the solution changed from yellow clear to reddish-brown turbid, anaerobic and stirred at room temperature for 24 hours, spin-dried after the reaction was completed, dissolved in dichloromethane, centrifuged, dissolved in dichloromethane and spin-dried with After repeated washing with ether, recrystallization with chloroform-ether gave reddish-brown platinum-silver nanoclusters [PtAg 12 (Erlotinib) 8 ] Cl 6 .
[0020] nanocluster [PtAg 12 (Erlotinib) 8 ] Cl 6 Chemical formula: PtAg 12 C 176 h 176 N 24 o 32 Cl 6 .
[0021] Elemental analysis [theoretical value (experimental value) (%)]: C: 43.66 (41.81); H: 3.66 (4.05); N: 6.94 (6.91).
[0022] ICP analys...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


